Cefodizime: Difference between revisions

	WikiDoc Resources for Cefodizime
Articles
Most recent articles on Cefodizime Most cited articles on Cefodizime Review articles on Cefodizime Articles on Cefodizime in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefodizime Images of Cefodizime Photos of Cefodizime Podcasts & MP3s on Cefodizime Videos on Cefodizime
Evidence Based Medicine
Cochrane Collaboration on Cefodizime Bandolier on Cefodizime TRIP on Cefodizime
Clinical Trials
Ongoing Trials on Cefodizime at Clinical Trials.gov Trial results on Cefodizime Clinical Trials on Cefodizime at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefodizime NICE Guidance on Cefodizime NHS PRODIGY Guidance FDA on Cefodizime CDC on Cefodizime
Books
Books on Cefodizime
News
Cefodizime in the news Be alerted to news on Cefodizime News trends on Cefodizime
Commentary
Blogs on Cefodizime
Definitions
Definitions of Cefodizime
Patient Resources / Community
Patient resources on Cefodizime Discussion groups on Cefodizime Patient Handouts on Cefodizime Directions to Hospitals Treating Cefodizime Risk calculators and risk factors for Cefodizime
Healthcare Provider Resources
Symptoms of Cefodizime Causes & Risk Factors for Cefodizime Diagnostic studies for Cefodizime Treatment of Cefodizime
Continuing Medical Education (CME)
CME Programs on Cefodizime
International
Cefodizime en Espanol Cefodizime en Francais
Business
Cefodizime in the Marketplace Patents on Cefodizime
Experimental / Informatics
List of terms related to Cefodizime

Cefodizime
Clinical data
ATC code	J01DD09 (WHO) ;
Identifiers
	IUPAC name (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-; methoxyiminoacetyl]amino}-3-{[5-(carboxymethyl)-; 4-methyl-1,3-thiazol-2-yl]sulfanylmethyl}-8-oxo-; 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;
PubChem CID	6321412;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C20H20N6O7S4
Molar mass	584.673 g/mol

Latest revision as of 19:09, 6 April 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Cefodizime is a cephalosporin.

@@ Line 24: / Line 24: @@
 | routes_of_administration =
 }}
+__NOTOC__
 {{SI}}
-{{EH}}
+{{CMG}}
+==Overview==
 '''Cefodizime''' is a [[cephalosporin]].
+==References==
+{{Reflist|2}}
 {{CephalosporinAntiBiotics}}
 [[Category:Cephalosporin antibiotics]]
-{{SIB}}
+[[Category:Drug]]
-{{WikiDoc Help Menu}}
-{{WS}}

v t e Antibacterials: cell wall disruption (J01C-J01D)
Internal to membrane/ (inhibit peptidoglycan subunit synthesis and transport)	Template:Navbox subgroup
Glycopeptide/ (inhibit PG chain elongation)	Vancomycin # (Oritavancin, Telavancin) · Teicoplanin (Dalbavancin) · Ramoplanin
Beta-lactams/ (inhibit cross-links with PBP)	Template:Navbox subgroup
Other	Template:Navbox subgroup
# = WHO-EM

Clinical data

ATC code	J01DD09 (WHO)
Identifiers
IUPAC name (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2- methoxyiminoacetyl]amino}-3-{[5-(carboxymethyl)- 4-methyl-1,3-thiazol-2-yl]sulfanylmethyl}-8-oxo- 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
PubChem CID	6321412
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₀H₂₀N₆O₇S₄
Molar mass	584.673 g/mol